Ultragenyx Pharmaceutical Company
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Investors
%20.jpg)
%20.jpg)
Technology:
Immunotherapy
Headquarters:
Novato, California, United States
Funding Status:
IPO
Founded Date:
2010
Estimated Revenue:
$10M to $50M
Employee Number:
501-1000
Industry:
PharmTech